Liberta RC DBS (rechargeable deep brain stimulation) features remote programming for treating people with movement disorders. Abbott says it requires the fewest recharges of any FDA-approved DBS system, needing just 10 recharge sessions a year for most users.
The system is also the first and only rechargeable DBS device compatible with Abbott’s proprietary NeuroSphere virtual clinic. NeuroSphere allows people to communicate with doctors, ensure proper settings and functionality and receive new treatment settings remotely.
This regulatory nod also comes just weeks after Medtronic won FDA approval for what it considers a “game-changing” DBS system. Abbott continues to progress with its own neurostimulation business as well. It won expanded MRI labeling from the FDA for its Proclaim system just a week ago.
“When our patients choose a rechargeable DBS system, it is often based on the smaller size of the device, but the tradeoff has always been how recharge frequency affects their lifestyle,” said Dr. Paul Larson, professor of neurosurgery at the University of Arizona. “The Liberta RC DBS system excels in both areas, as a compact rechargeable device with the lowest recharge requirement of any FDA-approved DBS system. This achievement, coupled with the integration of remote programming capabilities, is a significant advancement for patients.”
More about the Abbott Liberta RC DBS
The DBS device comes in at approximately the height and width of a smartwatch face. Abbott says it’s about 31% smaller than other commonly used, implantable, rechargeable DBS devices available in the U.S.
Under standard settings, the system requires recharging as seldom as every 37 days, or 10 times a year. It uses a wireless charger placed over the device. For users with a weekly charging schedule, they only need 30 minutes to do so.
The wireless system allows users to remain active while wearing it and they can fully recharge Liberta RC DBS twice before it needs to be plugged in again. Users can control the system on an Abbott-supplied patient controller or a secure, compatible iOS device. It offers helpful notifications and customizable settings for a personalized charging experience.
“In developing the Liberta RC DBS system, our focus has been on the unique experiences of individuals with chronic conditions like movement disorders,” said Pedro Malha,VP, neuromodulation, Abbott. “At Abbott, we’re committed to addressing these diverse needs. This system exemplifies our drive to providing patient-first solutions, combining effective therapy, effortless recharging, and remote programming capabilities.”
